A Pilot Study of Apligraf for the Treatment and Prevention of Recurrence of Excised Keloids
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Damien Bates, MD, PhD, FRACS (Plast.)
Organogenesis Inc.
Study Director - Heather Woolery-Lloyd, MD
University of Miami, Miller School of Medicine, Division of Cosmetic Dermatology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Miami, Miller School of Medicine, Division of Cosmetic Dermatology
Miami Beach, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2007
- Primary completion
- 31 Mar 2010
- Completion
- 31 Mar 2010
- Last update posted
- 19 Aug 2011
- Registered enrollment
- 30
- Registry id
- NCT00587587
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.